Delpor Awarded $340K NIH Grant for 3-month Long Acting Risperidone…
Delpor’s innovative Prozor technology receives support from the National Institute of Mental Health in an effort to reduce relapse in patients suffering from schizophrenia and bipolar disorder.
(PRWeb June 20, 2012)
Read the full story at http://www.prweb.com/releases/2012/6/prweb9617172.htmClick here for reuse options!
Copyright 2012 Biotechblog
Comments are closed.